猫疫苗市场报告：趋势、预测和竞争分析（至 2031 年）

全球猫疫苗市场的未来前景光明，在兽医诊所、宠物商店和线上零售通路都机会。预计到 2031 年全球猫疫苗市场规模将达到 19 亿美元，2025 年至 2031 年的复合年增长率为 7.2%。该市场的主要驱动力是猫数量的增加以及对预防猫传疾病的疫苗的巨大需求。

• Lucintel 预测，减毒活病毒疫苗因其高效率和刺激抗体和细胞介导免疫反应的能力，将继续成为该技术类别中最大的份额。
• 在销售管道类别中，兽医诊所预计将在预测期内经历最高的成长。
• 由于政府对保护猫免受严重疾病侵害的疫苗接种的严格规定以及美国养猫人数的增加，北美将继续成为最大的地区。

猫疫苗市场的策略性成长机会

猫疫苗市场的成长受到技术进步、宠物拥有量的增加以及对猫健康认识的推动，为关键应用提供了大量战略机会。

• 预防性疫苗接种的增加：预防性疫苗接种计划的增加提供了成长机会。人们越来越意识到疫苗接种的好处，从而推动了疫苗接种覆盖率的提高和猫科动物疾病发病率的降低。
• 开发先进的疫苗製剂：新一代疫苗，包括组合疫苗和个人化疫苗，有可能开闢全新的市场区隔。这些突破将解决特定的健康需求并提高疫苗的有效性，对市场成长产生正面影响。
• 疫苗接种方法的创新：正在开发新的疫苗接种策略，包括滴鼻剂和口服疫苗。这有望提高疫苗的接受度和接种率，并增加该技术成为主流的机会。
• 新兴市场的成长：宠物拥有量不断增加的新兴市场具有很大的扩张空间。客製化适合这些地区的解决方案将帮助您占领更大的市场份额。
• 重点关注猫科动物健康研究：针对开发新兴猫科动物疾病疫苗的研究投资具有成长潜力。应对新的健康威胁和改进现有的疫苗可以提高市场竞争力和创新。

这些因素正在塑造猫疫苗市场，重点是预防保健、技术进步和市场扩张。

猫疫苗市场驱动因素与挑战

猫疫苗市场受到多种市场驱动因素和挑战的影响，包括技术进步、经济因素和监管变化。因此，了解这些因素对于了解市场格局至关重要。

推动猫疫苗市场发展的因素有：

• 技术进步：疫苗技术的创新，包括新配方和给药方法，正在推动市场成长。这些进步正在提高疫苗的效力和给药的便利性，支持增加采用和扩大市场。
• 宠物拥有量不断增加：全球范围内宠物主人数量的不断增长推动了猫科动物疫苗的需求。随着越来越多的人开始饲养宠物并重视它们的健康，对有效疫苗接种解决方案的需求不断增加，从而提升了市场潜力。
• 着重预防性保健：人们越来越重视宠物的预防性保健，包括接种疫苗。这一趋势反映出人们越来越意识到疫苗接种在疾病预防中的重要性，从而促进了市场的成长。

猫咪疫苗市场面临的挑战是：

• 监管挑战：监管挑战：有关疫苗安全性和有效性的严格监管要求对製造商提出了挑战。了解这些法规并确保合规性可能会影响产品开发时间表和市场进入。
• 经济限制：原物料成本波动和疫苗可负担性等经济因素可能会影响市场动态。製造商必须平衡成本和品质才能在市场上保持竞争力。

这些驱动因素和挑战影响产品开发、市场开发和法规遵循度，从而塑造猫科动物疫苗市场。

目录

第一章执行摘要

第 2 章。

• 简介、背景和分类
• 供应链
• 产业驱动因素与挑战

第 3 章 市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）与预测（2025-2031）
• 全球猫科动物疫苗市场趋势（2019-2024 年）及预测（2025-2031 年）
• 全球猫科动物疫苗市场（依技术）
  • 减毒活病毒疫苗
  • 结合疫苗
  • 灭活疫苗
  • 次单位疫苗
  • 类毒素疫苗
  • DNA疫苗
  • 重组疫苗
• 全球猫科动物疫苗市场（按年龄划分）
  • 少于 6 个月
  • 6个月或以上
• 全球猫疫苗市场（按分销管道）
  • 兽医诊所
  • 宠物店
  • 网路零售商

第 4 章区域市场趋势与预测分析（2019-2031 年）

• 全球猫科动物疫苗市场（按地区）
• 北美猫科动物疫苗市场
• 欧洲猫科动物疫苗市场
• 亚太地区猫科动物疫苗市场
• 世界其他地区的猫疫苗市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球猫科疫苗市场成长机会（按技术）
  • 全球猫疫苗市场按年龄分類的成长机会
  • 全球猫疫苗市场按分销管道分類的成长机会
  • 全球猫科动物疫苗市场成长机会（按地区）
• 全球猫科动物疫苗市场的新趋势
• 战略分析
  • 新产品开发
  • 全球猫疫苗市场产能扩大
  • 全球猫科疫苗市场的企业合併
  • 认证和许可

第七章主要企业简介

• Elanco Animal Health
• Boehringer Ingelheim
• Merck
• Zoetis
• Bioveta Lubricant Additives Company

The future of the global cat vaccine market looks promising with opportunities in the veterinary clinic, pet store, and online retailer channels. The global cat vaccine market is expected to reach an estimated $1.9 billion by 2031 with a CAGR of 7.2% from 2025 to 2031. The major drivers for this market are the rising cat ownership and the significant demand for vaccinations to prevent cat-transmitted diseases.

• Lucintel forecasts that, within the technology category, attenuated live will remain the largest segment due to their high efficiency and ability to stimulate both antibody and cellular immune responses.
• Within the distribution channel category, veterinary clinics are expected to witness the highest growth over the forecast period.
• In terms of regions, North America will remain the largest region due to strict government regulations regarding vaccination in protecting cats from serious diseases and the rising adoption of cats in the USA.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Cat Vaccine Market

The cat vaccine market is witnessing several emerging trends that reflect advancements in technology, shifts in consumer preferences, and evolving regulatory requirements.

• Increased Focus on Combination Vaccines: There has been a shift toward combination vaccines that protect against multiple diseases at once. Pet owners benefit from this since it is more convenient for them and reduces the number of veterinary visits, thereby enhancing overall vaccination compliance.
• Advancements in Vaccine Delivery Methods: Nasal inhalation and oral vaccines are being increasingly used. These innovations aim to reduce the stress associated with the vaccination of cats and make the process easier. As such, preventive healthcare may be boosted.
• Development of Personalized Vaccines: The market is seeing the development of personalized vaccines tailored to the specific health needs of individual cats. This trend aims to enhance vaccine efficacy and reduce the risk of adverse reactions, improving overall health outcomes.
• Growth of Preventive Healthcare: There is a growing emphasis on preventive healthcare for pets, including vaccinations. This trend reflects a shift toward proactive health management and increased awareness of the importance of vaccination in preventing diseases.
• Expansion into Emerging Markets: The cat vaccine market is expanding into emerging markets where pet ownership is increasing. Companies are focusing on providing affordable and effective vaccines to meet the growing demand in these regions.

These trends are reshaping the cat vaccine market by enhancing vaccine technology, improving accessibility, and promoting preventive care.

Recent Developments in the Cat Vaccine Market

Several critical developments demonstrate the growth of the cat vaccine industry in terms of technology, focus on feline health, and expanding market opportunities.

• Introduction of Combination Vaccines: New combination vaccines are being introduced that protect against several feline diseases with a single dose. This development helps increase the efficiency of vaccinations and makes it easier for pet owners and veterinarians to vaccinate pets.
• Advancement in Vaccine Delivery Systems: The simplicity of administering vaccines has been enhanced by advances in vaccine delivery systems, such as intranasal and oral vaccines. These innovations aim to reduce cats' stress levels and increase compliance with vaccination programs.
• Expansion of Vaccine Research: Increasing research endeavors are targeting emerging feline diseases and improving current vaccine formulations. This expansion addresses new health challenges while making vaccination more effective and safer.
• Growth in Market Accessibility: Efforts are underway to ensure increased accessibility of vaccines in regions with no access, driven by rising pet ownership rates and increased awareness of feline health. This development includes the introduction of affordable vaccines and expansion into rural areas.
• Personalized Vaccine Development: Personalized vaccines that match the medical requirements of individual cats are being created. This personalized approach ensures that vaccines work better, minimizing adverse reactions and providing better-targeted and safe vaccination options.

These advancements boost vaccine technology, expand research initiatives, enhance accessibility, and improve market reach toward developing cat vaccine products.

Strategic Growth Opportunities for Cat Vaccine Market

Market growth in cat vaccines offers many strategic opportunities for key applications, propelled by advancements in technology, increasing pet ownership, and awareness of feline health.

• Increasing Preventive Vaccination: Increasing preventive vaccination programs present growing opportunities. The rising awareness of the benefits of vaccines calls for increased coverage levels and reduced frequency of occurrence for cat diseases.
• Development of Advanced Vaccine Formulations: The new generation of vaccines, including combined and personalized vaccines, could open up a completely new market segment. These breakthroughs address specific health needs and improve vaccine efficacy, positively impacting market growth.
• Innovation in Vaccine Delivery Methods: New strategies, such as nasal sprays or oral vaccines, are being developed for vaccination. This is expected to result in better acceptance and administration rates, thereby raising the chances for this technology to become mainstream.
• Emerging Market Growth: Expanding into emerging markets where pet ownership is increasing provides considerable scope for expansion. Customizing solutions that fit these areas can help capture a larger share of this market space.
• Focus on Feline Health Research: Investment in research aimed at developing vaccines for emerging feline diseases holds growth potential. Addressing new health threats and improving existing vaccines can enhance market competitiveness and innovation.

These factors are shaping the cat vaccine market with an emphasis on preventive care, technological advancements, and expanding markets.

Cat Vaccine Market Driver and Challenges

The cat vaccine market is influenced by several drivers and challenges, such as technological advancements, economic factors, and regulatory changes. Therefore, understanding these elements is crucial for navigating the market landscape.

The factors driving the cat vaccine market include:

• Technological Advancements: Innovations in vaccine technology, including new formulations and delivery methods, are driving market growth. These advancements enhance vaccine efficacy and ease of administration, supporting increased adoption and market expansion.
• Rising Pet Ownership: Increasing pet ownership globally is driving demand for cat vaccines. As more people acquire pets and prioritize their health, the need for effective vaccination solutions is growing, boosting market potential.
• Focus on Preventive Healthcare: There is a growing emphasis on preventive healthcare for pets, including vaccination. This trend reflects increased awareness of the importance of vaccination in preventing diseases, contributing to market growth.

Challenges in the cat vaccine market include:

• Regulatory Challenges: Stringent regulatory requirements for vaccine safety and efficacy pose challenges for manufacturers. Navigating these regulations and ensuring compliance can impact product development timelines and market entry.
• Economic Constraints: Economic factors, such as fluctuations in raw material costs and the affordability of vaccines, can impact market dynamics. Manufacturers need to balance cost and quality to maintain competitiveness in the market.

These drivers and challenges shape the cat vaccine market by influencing product development, market growth, and regulatory compliance.

List of Cat Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cat vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cat vaccine companies profiled in this report include-

• Elanco Animal Health
• Boehringer Ingelheim
• Merck
• Zoetis
• Bioveta

Cat Vaccine by Segment

The study includes a forecast for the global cat vaccine market by technology, age, distribution channel, and region.

Cat Vaccine Market by Technology [Analysis by Value from 2019 to 2031]:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

Cat Vaccine Market by Age [Analysis by Value from 2019 to 2031]:

• Below 6 Months
• Above 6 Months

Cat Vaccine Market by Distribution Channel [Analysis by Value from 2019 to 2031]:

• Veterinary Clinics
• Pet Stores
• Online Retailers

Cat Vaccine Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Cat Vaccine Market

Advancements in veterinary medicine, changing pet ownership trends, and increased awareness of animal health have led to the rapid evolution of the cat vaccine market. Recent advancements in this field indicate improvements in vaccine technology and feline health and safety efforts across various regions.

• United States: In the US, there has been significant progress with the introduction of new combination vaccines that can address multiple feline diseases in one shot. Improvements in vaccine formulations aim to enhance efficacy and reduce side effects. The market is also experiencing a transition toward longer-lasting immunity vaccines.
• China: China's focus is now on creating vaccines that combat emerging feline infections and improving existing immunization programs. There has been an upsurge in research activities within this market, supported by government initiatives for animal health and safety.
• Germany: Germany's market is progressing due to novel ways of delivering vaccines, such as intranasal or oral options for cats. These innovations aim to improve vaccination compliance and ease of administration. In addition, Germany seeks vaccines with broader protection against viral and bacterial infections.
• India: India requires cost-effective and efficient cat vaccines due to the rise in pet ownership and increased awareness of cat health issues across the country. Other developments include affordable vaccines whose coverage has been broadened into rural areas.
• Japan: In Japan, the market for cat vaccines has seen a revolution through personalized vaccinations tailored to the health status of individual cats. This involves creating effective vaccines that minimize harmful reactions, improving performance. Additionally, Japan is exploring new technologies for the production and distribution of vaccine products.

Features of the Global Cat Vaccine Market

Market Size Estimates: Cat vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Cat vaccine market size by technology, age, distribution channel, and region in terms of value ($B).

Regional Analysis: Cat vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different technologies, ages, distribution channels, and regions for the cat vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cat vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the cat vaccine market by technology (attenuated live vaccines, conjugate vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, and recombinant vaccines), age (below 6 months and above 6 months), distribution channel (veterinary clinics, pet stores, and online retailers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cat Vaccine Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Cat Vaccine Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Cat Vaccine Market by Technology
  • 3.3.1: Attenuated Live Vaccines
  • 3.3.2: Conjugate Vaccines
  • 3.3.3: Inactivated Vaccines
  • 3.3.4: Subunit Vaccines
  • 3.3.5: Toxoid Vaccines
  • 3.3.6: DNA Vaccines
  • 3.3.7: Recombinant Vaccines
• 3.4: Global Cat Vaccine Market by Age
  • 3.4.1: Below 6 Months
  • 3.4.2: Above 6 Months
• 3.5: Global Cat Vaccine Market by Distribution Channel
  • 3.5.1: Veterinary Clinics
  • 3.5.2: Pet Stores
  • 3.5.3: Online Retailers

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Cat Vaccine Market by Region
• 4.2: North American Cat Vaccine Market
  • 4.2.1: North American Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.2.2: North American Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.3: European Cat Vaccine Market
  • 4.3.1: European Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.3.2: European Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.4: APAC Cat Vaccine Market
  • 4.4.1: APAC Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.4.2: APAC Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers
• 4.5: ROW Cat Vaccine Market
  • 4.5.1: ROW Market by Technology: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, and Recombinant Vaccines
  • 4.5.2: ROW Market by Distribution Channel: Veterinary Clinics, Pet Stores, and Online Retailers

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Cat Vaccine Market by Technology
  • 6.1.2: Growth Opportunities for the Global Cat Vaccine Market by Age
  • 6.1.3: Growth Opportunities for the Global Cat Vaccine Market by Distribution Channel
  • 6.1.4: Growth Opportunities for the Global Cat Vaccine Market by Region
• 6.2: Emerging Trends in the Global Cat Vaccine Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Cat Vaccine Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cat Vaccine Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Elanco Animal Health
• 7.2: Boehringer Ingelheim
• 7.3: Merck
• 7.4: Zoetis
• 7.5: Bioveta Lubricant Additives Company